Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Psyched Wellness delivers preorders of its flagship product Calm and reopens online store

Preorders of Calm, a carefully extracted product which harnesses Amanita Muscaria’s restorative powers to soothe the body, tackle physical distress, and help with sleep, have now shipped to customers in 37 US states

Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) announced the successful production and delivery of its preorders of Calm, a carefully extracted product which harnesses Amanita Muscaria’s restorative powers to soothe the body, tackle physical distress, and help with sleep, in October this year.

According to the Toronto-based company, which is focused on producing products made from the medicinal properties of the Amanita Muscaria mushroom, Calm has now shipped to customers in 37 different US states.

Psyched Wellness said it projected October as the target for the delivery of Calm allowing sufficient time to incorporate feedback and product evolutions stemming from their initial pilot run.

READ: Psyched Wellness strengthens IP portfolio with update and provisional patent filing

In addition to achieving this milestone, the company said that its online store has reopened with an enhanced look and feel. The next production targets a late November delivery window. Moving forward, Psyched Wellness said it will increase the cadence of its production, product quantities, and “provide immediate fulfillment turnarounds.”

In a statement, Matthew Singh, who is the chief commercial officer at Psyched Wellness said: "It is a huge step forward to see Calm available and shipping to the US marketplace. Millions of Americans struggle with proper sleep, stress, and anxiety. We are excited for all to try Calm and experience the incredible benefits of a product that is wild-foraged, backed by science, and produced in GMP facilities.”

He added: “There is always pressure to rush a product to market; but, this scenario required adequate development, calibration, and scale before we progressed to mass distribution. Stay tuned for our next steps as we continue to grow our eCommerce business, activate our distributor networks, and our retailer partnerships."

The Canadian health supplements company focused on the distribution of mushroom-derived products is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.

Contact the author Uttara Choudhury at uttara@proactiveinvestors.com

Follow her on Twitter: @UttaraProactive

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK